Le salicylate de sodium est-il sûr pour les personnes allergiques ?
Non, les personnes allergiques aux salicylates doivent éviter son utilisation pour prévenir des réactions.
AllergiesSalicylatesRéactions
#5
Les personnes âgées sont-elles plus sensibles au salicylate de sodium ?
Oui, elles peuvent être plus sensibles aux effets secondaires et nécessitent une surveillance.
Personnes âgéesSensibilitéSalicylates
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Salicylate de sodium : Questions médicales les plus fréquentes",
"headline": "Salicylate de sodium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Salicylate de sodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Salicylate de sodium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acide salicylique",
"url": "https://questionsmedicales.fr/mesh/D020156",
"about": {
"@type": "MedicalCondition",
"name": "Acide salicylique",
"code": {
"@type": "MedicalCode",
"code": "D020156",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.410.595.608"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Salicylate de sodium",
"alternateName": "Sodium Salicylate",
"code": {
"@type": "MedicalCode",
"code": "D012980",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "L K Mamedova",
"url": "https://questionsmedicales.fr/author/L%20K%20Mamedova",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506."
}
},
{
"@type": "Person",
"name": "B J Bradford",
"url": "https://questionsmedicales.fr/author/B%20J%20Bradford",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506. Electronic address: bbradfor@ksu.edu."
}
},
{
"@type": "Person",
"name": "Yasmina M Abd-Elhakim",
"url": "https://questionsmedicales.fr/author/Yasmina%20M%20Abd-Elhakim",
"affiliation": {
"@type": "Organization",
"name": "Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt. Electronic address: yasmina_forensic@hotmail.com."
}
},
{
"@type": "Person",
"name": "Attia A A Moselhy",
"url": "https://questionsmedicales.fr/author/Attia%20A%20A%20Moselhy",
"affiliation": {
"@type": "Organization",
"name": "Department of Anatomy and Embryology, Faculty of Veterinary Medicine, Zagazig University, Egypt."
}
},
{
"@type": "Person",
"name": "Rasha R Beheiry",
"url": "https://questionsmedicales.fr/author/Rasha%20R%20Beheiry",
"affiliation": {
"@type": "Organization",
"name": "Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synthesis, Characterization and Application of a MIP-polyHIPE for Selective Extraction of Angiotensin II Receptor Antagonists Residues in Natural Waters.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36981793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20064878"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35969296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11357-022-00639-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decoding Angiotensin Receptors: TOMAHAQ-Based Detection and Quantification of Angiotensin Type-1 and Type-2 Receptors.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37681524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/JAHA.123.030791"
}
},
{
"@type": "ScholarlyArticle",
"name": "Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39264627",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.32862"
}
},
{
"@type": "ScholarlyArticle",
"name": "Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36459752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.10.026"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phénols",
"item": "https://questionsmedicales.fr/mesh/D010636"
},
{
"@type": "ListItem",
"position": 8,
"name": "Hydroxybenzoates",
"item": "https://questionsmedicales.fr/mesh/D062385"
},
{
"@type": "ListItem",
"position": 9,
"name": "Salicylates",
"item": "https://questionsmedicales.fr/mesh/D012459"
},
{
"@type": "ListItem",
"position": 10,
"name": "Acide salicylique",
"item": "https://questionsmedicales.fr/mesh/D020156"
},
{
"@type": "ListItem",
"position": 11,
"name": "Salicylate de sodium",
"item": "https://questionsmedicales.fr/mesh/D012980"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Salicylate de sodium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Salicylate de sodium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Salicylate de sodium",
"description": "Comment diagnostiquer une intoxication au salicylate de sodium ?\nQuels tests sont utilisés pour évaluer l'efficacité du salicylate de sodium ?\nQuels symptômes indiquent un surdosage de salicylate de sodium ?\nComment différencier le salicylate de sodium d'autres AINS ?\nQuels antécédents médicaux sont pertinents pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Salicylate de sodium",
"description": "Quels sont les effets secondaires courants du salicylate de sodium ?\nLe salicylate de sodium peut-il provoquer des réactions allergiques ?\nQuels symptômes indiquent une réaction sévère au salicylate de sodium ?\nComment le salicylate de sodium affecte-t-il le système digestif ?\nLe salicylate de sodium peut-il causer des troubles auditifs ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Salicylate de sodium",
"description": "Comment prévenir les effets secondaires du salicylate de sodium ?\nY a-t-il des interactions médicamenteuses à surveiller ?\nLes personnes âgées doivent-elles être prudentes avec le salicylate de sodium ?\nComment éviter une surdose de salicylate de sodium ?\nLe salicylate de sodium est-il sûr pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Salicylate de sodium",
"description": "Comment traiter une intoxication au salicylate de sodium ?\nLe salicylate de sodium est-il utilisé pour traiter l'arthrite ?\nQuelles alternatives existent au salicylate de sodium ?\nComment le salicylate de sodium est-il administré ?\nLe salicylate de sodium nécessite-t-il une prescription ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Salicylate de sodium",
"description": "Quelles complications peuvent survenir avec le salicylate de sodium ?\nLe salicylate de sodium peut-il causer des problèmes rénaux ?\nComment le salicylate de sodium affecte-t-il le foie ?\nQuelles sont les conséquences d'un surdosage ?\nLe salicylate de sodium peut-il affecter la coagulation sanguine ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Salicylate de sodium",
"description": "Qui est à risque d'effets secondaires du salicylate de sodium ?\nLes enfants peuvent-ils prendre du salicylate de sodium ?\nLes personnes atteintes de maladies cardiaques doivent-elles éviter le salicylate ?\nLe salicylate de sodium est-il sûr pour les personnes allergiques ?\nLes personnes âgées sont-elles plus sensibles au salicylate de sodium ?",
"url": "https://questionsmedicales.fr/mesh/D012980?mesh_terms=Angiotensin+Receptor+Antagonists#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication au salicylate de sodium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'historique médical et des tests sanguins pour mesurer les niveaux de salicylate."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité du salicylate de sodium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de douleur et d'inflammation, ainsi que des évaluations cliniques, sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un surdosage de salicylate de sodium ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des acouphènes, des nausées et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment différencier le salicylate de sodium d'autres AINS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le salicylate de sodium a des propriétés anti-inflammatoires spécifiques et un profil d'effets secondaires distinct."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont pertinents pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles gastro-intestinaux ou d'allergies aux salicylates sont importants."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants du salicylate de sodium ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des troubles gastro-intestinaux, des vertiges et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium peut-il provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques, comme des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction sévère au salicylate de sodium ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des difficultés respiratoires ou un gonflement du visage nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Comment le salicylate de sodium affecte-t-il le système digestif ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des irritations gastriques, des ulcères ou des saignements gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium peut-il causer des troubles auditifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des acouphènes ou une perte auditive temporaire peuvent survenir avec un surdosage."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets secondaires du salicylate de sodium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour prévenir les effets secondaires, il est conseillé de suivre les doses recommandées et de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Y a-t-il des interactions médicamenteuses à surveiller ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le salicylate de sodium peut interagir avec des anticoagulants et d'autres AINS."
}
},
{
"@type": "Question",
"name": "Les personnes âgées doivent-elles être prudentes avec le salicylate de sodium ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de subir des effets secondaires et doivent être surveillées."
}
},
{
"@type": "Question",
"name": "Comment éviter une surdose de salicylate de sodium ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respectez toujours les doses prescrites et évitez l'automédication sans avis médical."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium est-il sûr pendant la grossesse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Son utilisation pendant la grossesse doit être discutée avec un médecin en raison des risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment traiter une intoxication au salicylate de sodium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure l'administration de charbon actif et une surveillance médicale étroite."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium est-il utilisé pour traiter l'arthrite ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent prescrit pour soulager la douleur et l'inflammation associées à l'arthrite."
}
},
{
"@type": "Question",
"name": "Quelles alternatives existent au salicylate de sodium ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres AINS comme l'ibuprofène ou le naproxène peuvent être utilisés comme alternatives."
}
},
{
"@type": "Question",
"name": "Comment le salicylate de sodium est-il administré ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être administré par voie orale sous forme de comprimés ou de solutions liquides."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium nécessite-t-il une prescription ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être disponible sans ordonnance, mais une consultation médicale est recommandée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le salicylate de sodium ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des saignements gastro-intestinaux, des ulcères et des réactions allergiques graves."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium peut-il causer des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation prolongée peut entraîner des problèmes rénaux, surtout chez les personnes à risque."
}
},
{
"@type": "Question",
"name": "Comment le salicylate de sodium affecte-t-il le foie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des doses élevées peuvent causer des dommages hépatiques, nécessitant une surveillance régulière."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'un surdosage ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un surdosage peut entraîner des troubles respiratoires, des convulsions et un coma dans les cas graves."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium peut-il affecter la coagulation sanguine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut affecter la coagulation, augmentant le risque de saignement, surtout avec d'autres anticoagulants."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets secondaires du salicylate de sodium ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'ulcères, d'allergies ou de maladies rénales sont à risque."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils prendre du salicylate de sodium ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation chez les enfants doit être évitée en raison du risque de syndrome de Reye."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies cardiaques doivent-elles éviter le salicylate ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent consulter un médecin avant de l'utiliser en raison des risques cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Le salicylate de sodium est-il sûr pour les personnes allergiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les personnes allergiques aux salicylates doivent éviter son utilisation pour prévenir des réactions."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus sensibles au salicylate de sodium ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être plus sensibles aux effets secondaires et nécessitent une surveillance."
}
}
]
}
]
}
Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt. Electronic address: yasmina_forensic@hotmail.com.
College of Animal Science and Technology, Anhui Agricultural University, Hefei 230036, China.
Anhui Province Key Laboratory of Local Livestock and Poultry Genetic Resource Conservation and Bio-Breeding, Anhui Agricultural University, Hefei 230036, China.
Polymers via high internal phase emulsion (polyHIPEs) were molecularly imprinted with Irbesartan, an antihypertensive drug belonging to the class of angiotensin II receptor antagonists (sartan drugs),...
Background The renin-angiotensin system plays a crucial role in human physiology, and its main hormone, angiotensin, activates 2 G-protein-coupled receptors, the angiotensin type-1 and type-2 receptor...
Thrombotic microangiopathy (TMA) on kidney biopsy is a pattern of endothelial injury commonly seen in malignant hypertension (mHTN), but treatment strategies are not well established....
To evaluate the kidney outcomes of angiotensin receptor-neprilysin inhibitor (ARNI), specifically sacubitril/valsartan, vs angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocke...
This single-center cohort study enrolled consecutive patients in China diagnosed with mHTN-associated TMA through kidney biopsy from January 2008 to June 2023. Follow-up was conducted until the conclu...
Treatment with sacubitril/valsartan or ACEI/ARBs during hospitalization and after discharge....
The primary outcome was a composite of kidney recovery: a 50% decrease in serum creatinine level, decrease in serum creatinine levels to the reference range, or kidney survival free from dialysis for ...
Among the 217 patients (mean [SD] age, 35.9 [8.8] years; 188 men [86.6%]) included in the study, 66 (30.4%) received sacubitril/valsartan and 151 (69.6%) received ACEI/ARBs at baseline. Sacubitril/val...
In this cohort study, sacubitril/valsartan treatment was associated with a potential kidney function benefit in patients with mHTN-associated TMA compared with ACEI/ARB treatment. The findings suggest...
The superiority of angiotensin receptor-neprilysin inhibitor (ARNI) over angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin receptor blocker (ARB) has not been reassessed after the public...
Medications used to treat hypertension may affect fracture risk. This study investigated fracture risk for users of angiotensin converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers ...
Angiotensin receptor blockers (ARBs) used in the treatment of hypertension and potentially in SARS-CoV-2 infection exhibit inverse agonist effects at angiotensin AR1 receptors, suggesting the receptor...
The aim of this study was to conduct a systematic review and meta-analysis to investigate the effect of the premorbid use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker...
Embase, the Cochrane Central Register of Controlled Trials, and MEDLINE were searched for studies based on the below eligibility criteria. The protocol was registered at the PROSPERO (CRD42022309129)....
Eligibility criteria were as follows: (1) randomized controlled trials, cohort studies, cross-sectional studies, (2) patients with sepsis aged ≥16 years, and (3) received premorbid ACEI/ARB, or not....
The patient and study characteristics and outcomes were extracted. All analyses were presented with the use of random-effects models. The primary outcome was short-term mortality defined as ≤30-day, i...
Fifteen studies (N = 96,159) met the eligibility criteria. Of these, eleven studies (N = 40,360) reported unadjusted short-term mortalities. The pooled odds ratio (OR) of short-term mortality with the...
In this meta-analysis, the premorbid ACEI/ARB was associated with significantly lower short-term mortality in patients with sepsis despite the significantly higher risk of AKI....
Guidelines suggest that adults with diabetes and kidney disease receive treatment with angiotensin-converting-enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). This is an update of a Co...
We compared the efficacy and safety of ACEi and ARB therapy (either as monotherapy or in combination) on cardiovascular and kidney outcomes in adults with diabetes and kidney disease....
We searched the Cochrane Kidney and Transplants Register of Studies to 17 March 2024 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register...
We included studies evaluating ACEi or ARB alone or in combination, compared to each other, placebo or no treatment in people with diabetes and kidney disease....
Two authors independently assessed the risk of bias and extracted data. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios (RR) and their...
One hundred and nine studies (28,341 randomised participants) were eligible for inclusion. Overall, the risk of bias was high. Compared to placebo or no treatment, ACEi may make little or no differenc...
ACEi or ARB may make little or no difference to all-cause and cardiovascular death compared to placebo or no treatment in people with diabetes and kidney disease but may prevent kidney failure. ARB ma...
For persons with proteinuria, angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) are treatment mainstays for reducing kidney disease progression. Guidelines f...